ADMA Biologics Inc (ADMA)
21.18
-0.12
(-0.56%)
USD |
NASDAQ |
Nov 22, 16:00
21.21
+0.03
(+0.14%)
After-Hours: 20:00
ADMA Biologics Price: 21.18 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 21.45 | 21.48 | 20.88 | 21.18 | 2.099M |
Nov 21, 2024 | 21.60 | 21.70 | 20.87 | 21.30 | 2.265M |
Nov 20, 2024 | 20.63 | 21.40 | 20.47 | 21.37 | 2.246M |
Nov 19, 2024 | 19.29 | 20.65 | 19.29 | 20.63 | 2.204M |
Nov 18, 2024 | 19.04 | 19.59 | 18.90 | 19.54 | 2.713M |
Nov 15, 2024 | 20.23 | 20.34 | 19.02 | 19.04 | 3.624M |
Nov 14, 2024 | 21.25 | 21.33 | 20.18 | 20.20 | 3.216M |
Nov 13, 2024 | 22.11 | 22.55 | 21.46 | 21.47 | 2.441M |
Nov 12, 2024 | 22.34 | 22.46 | 21.74 | 21.78 | 4.186M |
Nov 11, 2024 | 23.00 | 23.64 | 21.84 | 22.48 | 4.841M |
Nov 08, 2024 | 20.76 | 23.52 | 20.00 | 22.62 | 9.717M |
Nov 07, 2024 | 19.80 | 20.06 | 19.63 | 19.72 | 4.428M |
Nov 06, 2024 | 19.67 | 19.86 | 19.17 | 19.67 | 4.327M |
Nov 05, 2024 | 19.08 | 19.25 | 18.57 | 18.83 | 2.216M |
Nov 04, 2024 | 19.46 | 19.55 | 18.95 | 19.11 | 4.537M |
Nov 01, 2024 | 18.29 | 20.18 | 18.24 | 19.37 | 11.74M |
Oct 31, 2024 | 16.74 | 16.85 | 16.09 | 16.31 | 2.915M |
Oct 30, 2024 | 16.85 | 17.03 | 16.37 | 16.96 | 2.334M |
Oct 29, 2024 | 16.35 | 16.75 | 16.20 | 16.71 | 2.311M |
Oct 28, 2024 | 15.94 | 16.68 | 15.88 | 16.43 | 2.735M |
Oct 25, 2024 | 16.11 | 16.35 | 15.76 | 15.81 | 2.730M |
Oct 24, 2024 | 15.77 | 16.00 | 15.61 | 15.96 | 2.104M |
Oct 23, 2024 | 15.60 | 15.76 | 15.37 | 15.69 | 2.907M |
Oct 22, 2024 | 15.50 | 15.79 | 15.34 | 15.67 | 2.655M |
Oct 21, 2024 | 15.69 | 15.96 | 15.33 | 15.62 | 3.414M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.09
Minimum
Oct 11 2021
22.62
Maximum
Nov 08 2024
4.219
Average
2.94
Median
Apr 07 2020
Price Benchmarks
Corcept Therapeutics Inc | 57.54 |
Madrigal Pharmaceuticals Inc | 347.45 |
Assembly Biosciences Inc | 15.04 |
TG Therapeutics Inc | 35.07 |
Krystal Biotech Inc | 190.40 |
Price Related Metrics
PE Ratio | 75.64 |
PS Ratio | 13.13 |
Price to Book Value | 21.59 |
Price to Free Cash Flow | 63.78 |
Earnings Yield | 1.32% |
Market Cap | 5.007B |
Operating PE Ratio | 43.75 |
Normalized PE Ratio | 75.64 |